長期借入金、Transfer To Other Capital Surplus From Legal Capital Surplus、製品期首たな卸高他2件
- 【期間】
| 年度 | 長期借入金 | Transfer To Other Capital Surplus From Legal Capital Surplus | 製品期首たな卸高 | 研究開発費 - ライフサイエンス | 技術研究費 |
|---|
| 2008/03 | 171億 | | - | | 83億 | | - | | - | |
| 2009/03 | 586億 | +243.1% | - | | - | | - | | - | |
| 2010/03 | 678億 | +15.7% | - | | - | | - | | - | |
| 2011/03 | 681億 | +0.4% | - | | - | | - | | - | |
| 2012/03 | 731億 | +7.4% | - | | - | | - | | - | |
| 2013/03 | 1018億 | +39.2% | - | | - | | - | | 89.1億 | |
| 2014/03 | 1643億 | +61.4% | - | | - | | - | | 78.2億 | -12.2% |
| 2015/03 | 1916億 | +16.6% | - | | - | | - | | 92.4億 | +18.2% |
| 2016/03 | 1729億 | -9.7% | - | | - | | - | | 75.1億 | -18.7% |
| 2017/03 | 1606億 | -7.1% | - | | - | | - | | 64.7億 | -13.8% |
| 2018/03 | 1195億 | -25.6% | - | | - | | - | | 68億 | +5% |
| 2019/03 | 1094億 | -8.5% | - | | - | | - | | 70.8億 | +4.1% |
| 2020/03 | 943億 | -13.9% | - | | - | | - | | 80.1億 | +13.2% |
| 2021/03 | 828億 | -12.1% | - | | - | | - | | 95.5億 | +19.2% |
| 2022/03 | 680億 | -17.9% | - | | - | | 28.6億 | | 113億 | +18.5% |
| 2023/03 | 1183億 | +74.1% | - | | - | | 28億 | -2.1% | 123億 | +8.9% |
| 2024/03 | 633億 | -46.5% | - | | - | | 29.9億 | +6.9% | 131億 | +6.5% |
